Cargando…
Sub-therapeutic vasopressin but not therapeutic vasopressin improves gastrointestinal microcirculation in septic rats: A randomized, placebo-controlled, blinded trial
INTRODUCTION: Sepsis impairs gastrointestinal microcirculation and it is hypothesized that this might increase patient’s mortality. Sub-therapeutic vasopressin improves gastric microcirculation under physiologic conditions whereas a therapeutic dosing regimen seems to be rather detrimental. However,...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8460032/ https://www.ncbi.nlm.nih.gov/pubmed/34555053 http://dx.doi.org/10.1371/journal.pone.0257034 |
_version_ | 1784571659129192448 |
---|---|
author | Schulz, Jan Bauer, Inge Herminghaus, Anna Picker, Olaf Truse, Richard Vollmer, Christian |
author_facet | Schulz, Jan Bauer, Inge Herminghaus, Anna Picker, Olaf Truse, Richard Vollmer, Christian |
author_sort | Schulz, Jan |
collection | PubMed |
description | INTRODUCTION: Sepsis impairs gastrointestinal microcirculation and it is hypothesized that this might increase patient’s mortality. Sub-therapeutic vasopressin improves gastric microcirculation under physiologic conditions whereas a therapeutic dosing regimen seems to be rather detrimental. However, the effects of sub-therapeutic vasopressin on gastrointestinal microcirculation in sepsis are largely unknown. Therefore, we conducted this trial to investigate the effect of sub-therapeutic as well as therapeutic vasopressin on gastrointestinal microcirculation in sepsis. METHODS: 40 male Wistar rats were randomized into 4 groups. Colon ascendens stent peritonitis (CASP)-surgery was performed to establish mild or moderate sepsis. 24 hours after surgery, animals received either vasopressin with increasing dosages every 30 min (6.75, 13.5 (sub-therapeutic), 27 mU · kg(-1) · h(-1) (therapeutic)) or vehicle. Microcirculatory oxygenation (μHBO(2)) of the colon was recorded for 90 min using tissue reflectance spectrophotometry. Intestinal microcirculatory perfusion (total vessel density (TVD; mm/mm(2)) and perfused vessel density (PVD; mm/mm(2))) were measured using incident dark field-Imaging at baseline and after 60 min. RESULTS: In mild as well as in moderate septic animals with vehicle-infusion intestinal μHbO(2), TVD and PVD remained constant. In contrast, in moderate sepsis, sub-therapeutic vasopressin with 13.5 mU · kg(-1) · h(-1) elevated intestinal μHBO(2) (+ 6.1 ± 5.3%; p < 0.05 vs. baseline) and TVD (+ 5.2 ± 3.0 mm/mm(2); p < 0.05 vs. baseline). μHBO(2), TVD and PVD were significantly increased compared to moderate sepsis alone. However, therapeutic vasopressin did not change intestinal microcirculation. In mild septic animals sub-therapeutic as well as therapeutic vasopressin had no relevant effect on gastrointestinal microcirculation. Systemic blood pressure remained constant in all groups. CONCLUSION: Sub-therapeutic vasopressin improves gastrointestinal microcirculatory oxygenation in moderate sepsis without altering systemic blood pressure. This protective effect seems to be mediated by an enhanced microcirculatory perfusion and thereby increased oxygen supply. In contrast, therapeutic vasopressin did not show this beneficial effect. |
format | Online Article Text |
id | pubmed-8460032 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-84600322021-09-24 Sub-therapeutic vasopressin but not therapeutic vasopressin improves gastrointestinal microcirculation in septic rats: A randomized, placebo-controlled, blinded trial Schulz, Jan Bauer, Inge Herminghaus, Anna Picker, Olaf Truse, Richard Vollmer, Christian PLoS One Research Article INTRODUCTION: Sepsis impairs gastrointestinal microcirculation and it is hypothesized that this might increase patient’s mortality. Sub-therapeutic vasopressin improves gastric microcirculation under physiologic conditions whereas a therapeutic dosing regimen seems to be rather detrimental. However, the effects of sub-therapeutic vasopressin on gastrointestinal microcirculation in sepsis are largely unknown. Therefore, we conducted this trial to investigate the effect of sub-therapeutic as well as therapeutic vasopressin on gastrointestinal microcirculation in sepsis. METHODS: 40 male Wistar rats were randomized into 4 groups. Colon ascendens stent peritonitis (CASP)-surgery was performed to establish mild or moderate sepsis. 24 hours after surgery, animals received either vasopressin with increasing dosages every 30 min (6.75, 13.5 (sub-therapeutic), 27 mU · kg(-1) · h(-1) (therapeutic)) or vehicle. Microcirculatory oxygenation (μHBO(2)) of the colon was recorded for 90 min using tissue reflectance spectrophotometry. Intestinal microcirculatory perfusion (total vessel density (TVD; mm/mm(2)) and perfused vessel density (PVD; mm/mm(2))) were measured using incident dark field-Imaging at baseline and after 60 min. RESULTS: In mild as well as in moderate septic animals with vehicle-infusion intestinal μHbO(2), TVD and PVD remained constant. In contrast, in moderate sepsis, sub-therapeutic vasopressin with 13.5 mU · kg(-1) · h(-1) elevated intestinal μHBO(2) (+ 6.1 ± 5.3%; p < 0.05 vs. baseline) and TVD (+ 5.2 ± 3.0 mm/mm(2); p < 0.05 vs. baseline). μHBO(2), TVD and PVD were significantly increased compared to moderate sepsis alone. However, therapeutic vasopressin did not change intestinal microcirculation. In mild septic animals sub-therapeutic as well as therapeutic vasopressin had no relevant effect on gastrointestinal microcirculation. Systemic blood pressure remained constant in all groups. CONCLUSION: Sub-therapeutic vasopressin improves gastrointestinal microcirculatory oxygenation in moderate sepsis without altering systemic blood pressure. This protective effect seems to be mediated by an enhanced microcirculatory perfusion and thereby increased oxygen supply. In contrast, therapeutic vasopressin did not show this beneficial effect. Public Library of Science 2021-09-23 /pmc/articles/PMC8460032/ /pubmed/34555053 http://dx.doi.org/10.1371/journal.pone.0257034 Text en © 2021 Schulz et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Schulz, Jan Bauer, Inge Herminghaus, Anna Picker, Olaf Truse, Richard Vollmer, Christian Sub-therapeutic vasopressin but not therapeutic vasopressin improves gastrointestinal microcirculation in septic rats: A randomized, placebo-controlled, blinded trial |
title | Sub-therapeutic vasopressin but not therapeutic vasopressin improves gastrointestinal microcirculation in septic rats: A randomized, placebo-controlled, blinded trial |
title_full | Sub-therapeutic vasopressin but not therapeutic vasopressin improves gastrointestinal microcirculation in septic rats: A randomized, placebo-controlled, blinded trial |
title_fullStr | Sub-therapeutic vasopressin but not therapeutic vasopressin improves gastrointestinal microcirculation in septic rats: A randomized, placebo-controlled, blinded trial |
title_full_unstemmed | Sub-therapeutic vasopressin but not therapeutic vasopressin improves gastrointestinal microcirculation in septic rats: A randomized, placebo-controlled, blinded trial |
title_short | Sub-therapeutic vasopressin but not therapeutic vasopressin improves gastrointestinal microcirculation in septic rats: A randomized, placebo-controlled, blinded trial |
title_sort | sub-therapeutic vasopressin but not therapeutic vasopressin improves gastrointestinal microcirculation in septic rats: a randomized, placebo-controlled, blinded trial |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8460032/ https://www.ncbi.nlm.nih.gov/pubmed/34555053 http://dx.doi.org/10.1371/journal.pone.0257034 |
work_keys_str_mv | AT schulzjan subtherapeuticvasopressinbutnottherapeuticvasopressinimprovesgastrointestinalmicrocirculationinsepticratsarandomizedplacebocontrolledblindedtrial AT baueringe subtherapeuticvasopressinbutnottherapeuticvasopressinimprovesgastrointestinalmicrocirculationinsepticratsarandomizedplacebocontrolledblindedtrial AT herminghausanna subtherapeuticvasopressinbutnottherapeuticvasopressinimprovesgastrointestinalmicrocirculationinsepticratsarandomizedplacebocontrolledblindedtrial AT pickerolaf subtherapeuticvasopressinbutnottherapeuticvasopressinimprovesgastrointestinalmicrocirculationinsepticratsarandomizedplacebocontrolledblindedtrial AT truserichard subtherapeuticvasopressinbutnottherapeuticvasopressinimprovesgastrointestinalmicrocirculationinsepticratsarandomizedplacebocontrolledblindedtrial AT vollmerchristian subtherapeuticvasopressinbutnottherapeuticvasopressinimprovesgastrointestinalmicrocirculationinsepticratsarandomizedplacebocontrolledblindedtrial |